← Open Payments lookup

KAYLA CASTANEDA: Open Payments

NPI 1174773857 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$40,240 in 122 payments from 14 companies in 2025. Trend: 2023 $2,417 · 2024 $6,574 · 2025 $40,240

Speaker / faculty: $13,805Speaker / faculty: $10,761Travel & lodging: $10,414Food & beverage: $3,649Consulting: $1,598Education: $13
CompanyPaymentsAmount
Eisai Inc.62$21,815
GlaxoSmithKline, LLC.30$13,732
PFIZER INC.2$3,205
Globus Medical, Inc.4$455
Janssen Biotech, Inc.2$204
Merck Sharp & Dohme LLC6$160
Daiichi Sankyo Inc.2$138
Pharmacosmos Therapeutics Inc.1$122
Regeneron Healthcare Solutions, Inc.1$121
AstraZeneca Pharmaceuticals LP6$118

Products named: Lenvima, JEMPERLI, ZEJULA, TIVDAK, Senza, RYBREVANT, LYNPARZA, Enhertu.

Industry payments across TX — which companies pay providers there.